1. Home
  2. RAIL vs MGNX Comparison

RAIL vs MGNX Comparison

Compare RAIL & MGNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RAIL
  • MGNX
  • Stock Information
  • Founded
  • RAIL 1901
  • MGNX 2000
  • Country
  • RAIL United States
  • MGNX United States
  • Employees
  • RAIL N/A
  • MGNX N/A
  • Industry
  • RAIL Railroads
  • MGNX Biotechnology: Pharmaceutical Preparations
  • Sector
  • RAIL Industrials
  • MGNX Health Care
  • Exchange
  • RAIL Nasdaq
  • MGNX Nasdaq
  • Market Cap
  • RAIL 231.4M
  • MGNX 257.3M
  • IPO Year
  • RAIL N/A
  • MGNX 2013
  • Fundamental
  • Price
  • RAIL $8.89
  • MGNX $3.17
  • Analyst Decision
  • RAIL
  • MGNX Hold
  • Analyst Count
  • RAIL 0
  • MGNX 10
  • Target Price
  • RAIL N/A
  • MGNX $7.17
  • AVG Volume (30 Days)
  • RAIL 261.3K
  • MGNX 485.4K
  • Earning Date
  • RAIL 11-12-2024
  • MGNX 11-05-2024
  • Dividend Yield
  • RAIL N/A
  • MGNX N/A
  • EPS Growth
  • RAIL N/A
  • MGNX N/A
  • EPS
  • RAIL N/A
  • MGNX N/A
  • Revenue
  • RAIL $548,333,000.00
  • MGNX $141,329,000.00
  • Revenue This Year
  • RAIL $63.43
  • MGNX $174.73
  • Revenue Next Year
  • RAIL $5.04
  • MGNX N/A
  • P/E Ratio
  • RAIL N/A
  • MGNX N/A
  • Revenue Growth
  • RAIL 52.11
  • MGNX 16.68
  • 52 Week Low
  • RAIL $2.40
  • MGNX $2.95
  • 52 Week High
  • RAIL $16.10
  • MGNX $21.88
  • Technical
  • Relative Strength Index (RSI)
  • RAIL 38.38
  • MGNX 41.22
  • Support Level
  • RAIL $8.74
  • MGNX $3.10
  • Resistance Level
  • RAIL $10.98
  • MGNX $3.45
  • Average True Range (ATR)
  • RAIL 0.67
  • MGNX 0.20
  • MACD
  • RAIL -0.02
  • MGNX -0.01
  • Stochastic Oscillator
  • RAIL 8.75
  • MGNX 17.24

About RAIL FreightCar America Inc.

FreightCar America Inc is a manufacturer of railcars and components, serving diverse transportation needs primarily in North America. The company designs and produces a wide range of railcar types, including box cars, hoppers, covered hoppers, gondolas, and flat cars for both intermodal and non-intermodal freight. Its clientele includes shippers, railroads, and financial institutions. The company has two segments: Manufacturing and Parts. The Manufacturing segment encompasses new railcar manufacturing, used railcar sales, leasing, and major rebuilds, while the Parts segment, along with corporate activities, constitutes Corporate and Other. The company's revenue is predominantly derived from its Manufacturing segment, with all revenue generated within the United States.

About MGNX MacroGenics Inc.

Macrogenics Inc is a biotechnology company focused on discovering and developing antibody-based therapeutics for the treatment of cancer. Its product includes MARGENZA, which is for the treatment of adult patients with metastatic HER2-positive breast cancer. It's a pipeline of product candidates designed to target either various tumor-associated antigens or immune checkpoint molecules. Its pipeline MGC018 (B7-H3), Lorigerlimab (PD-1 x CTLA-4), Tebotelimab (PD-1 x LAG-3), MGD024 (CD123 x CD3), IMGC936 (ADAM9), Enoblituzumab (anti-B7-H3), Retifanlimab (PD-1), and MGD014 (HIV x CD3).

Share on Social Networks: